Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3929]

Recurrent non-invasive breast tumours may not always be related to the primary...

Dr Tanjina Kader - University of Melbourne, Melbourne, Australia

Recurrent non-invasive breast tumours may not always be related to the primary lesion ( Dr Tanjina Kader - University of Melbourne, Melbourne, Australia )

Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin...

Prof Benoit You - Hospices Civils de Lyon, Lyon, France

Safety and efficacy of olaparib plus metronomic cyclophosphamide and metformin in advanced/metastatic endometrial cancer ( Prof Benoit You - Hospices Civils de Lyon, Lyon, France )

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )

The adverse events atlas, towards a strategy to predict synergistic adverse...

Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands

The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies ( Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands )

Safety and efficacy of the oral ATR inhibitor elimusertib in advanced solid...

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

Safety and efficacy of the oral ATR inhibitor elimusertib in advanced solid tumours with DNA damage response defects ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1...

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Novel COVID-19 vaccine for B-cell deficient patients

Prof Juliane Walz - University Hospital Tübingen, Tübingen, Germany

Novel COVID-19 vaccine for B-cell deficient patients ( Prof Juliane Walz - University Hospital Tübingen, Tübingen, Germany )

FAP-targeted PET imaging in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA

FAP-targeted PET imaging in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )

FAP-targeted molecular radiotherapy in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA

FAP-targeted molecular radiotherapy in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )

Immune gene signatures for predicting response to neoadjuvant...

Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda...

Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC ( Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )

EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari

EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )

Minimal residual disease in multiple myeloma

Prof Ola Landgren - University of Miami, Miami, USA

Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )

More from ecancer